SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PETV

PetVivo Holdings, Inc. (OTC:PETV)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$0.31+$0.05 (+18.77%)
 
Market cap
$11.8M
Insider Score
Health Score
Listed since
Sep 8, 2014
Market Cap$11.76M-75.2%
Revenue (ttm)$1.09M-22.5%
Net Income-$8.72M+8.2%
EPS-$0.25+38.4%
Shares Out37.95M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,497
Open$0.27
Previous Close$0.26
Day's Range$0.27 - $0.31
52-Week Range$0.24 - $1.44
Beta1.44
Analystsn/a
Price Targetn/a
Earnings DateFeb 16, 2027
+18.77% (1D)
No price history available.

About PETV

PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.

Address
5251 Edina Industrial Boulevard, Edina, MN, 55439, US
Market Cap
12 million
Employees
22
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$96.15K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Distressed
From PETV’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
+18.77%
5 Days
-31.11%
1 Month
-54.90%
6 Months
-60.26%
1 Year
-75.20%

$PETV stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in PETV holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PETV's directors and management

Net Shares Purchased by Insiders−80k−40k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PETV Estimated quarterly lobbying spending

Source: U.S. Senate LDA

PETV Revenue by Segment

$669.45KTotal
Unrealized Loss on Change in Derivative Liabilities$320.40K47.86%
Loss on termination of license agreement$237.53K35.48%
Other Income$111.52K16.66%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New PETV patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PETV from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from PETV’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
0
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
18
Sells
0
Buy Value
$96.15K
Distinct Buyers
1

Insider Score Trend Over Time

+0.0 since Sep 25
0255075100Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 39.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 25Sep 29Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.